Proteomics and phosphoproteomics of chordoma biopsies reveal alterations in multiple pathways and aberrant kinases activities

BACKGROUND: Chordoma is a slow-growing but malignant subtype of bone sarcoma with relatively high recurrence rates and high resistance to chemotherapy. It is urgent to understand the underlying regulatory networks to determine more effective potential targets. Phosphorylative regulation is currently...

Descripción completa

Detalles Bibliográficos
Autores principales: Hang, Jing, Ouyang, Hanqiang, Wei, Feng, Zhong, Qihang, Yuan, Wanqiong, Jiang, Liang, Liu, Zhongjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563620/
https://www.ncbi.nlm.nih.gov/pubmed/36248973
http://dx.doi.org/10.3389/fonc.2022.941046

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563620/
https://www.ncbi.nlm.nih.gov/pubmed/36248973
http://dx.doi.org/10.3389/fonc.2022.941046

Ejemplares similares